{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T02:41:58Z","timestamp":1751251318435,"version":"3.37.3"},"reference-count":32,"publisher":"Oxford University Press (OUP)","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 GM075766-09","K23 AR063764"],"award-info":[{"award-number":["T32 GM075766-09","K23 AR063764"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/jpids\/pix052","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T15:12:01Z","timestamp":1496416321000},"source":"Crossref","is-referenced-by-count":4,"title":["Incidence of Pneumocystis jirovecii and Adverse Events Associated With Pneumocystis Prophylaxis in Children Receiving Glucocorticoids"],"prefix":"10.1093","author":[{"given":"Matthew L.","family":"Basiaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle E.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey S.","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Ogdie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,7,13]]},"reference":[{"key":"key\n\t\t\t\t20170713025134_CIT0001","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1002\/art.21378","article-title":"The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids","volume":"52","year":"2005","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170713025134_CIT0002","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","article-title":"Juvenile idiopathic arthritis","volume":"369","year":"2007","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170713025134_CIT0003","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.crohns.2014.04.005","article-title":"Consensus guidelines of ECCO\/ESPGHAN on the medical management of pediatric Crohn\u2019s disease","volume":"8","author":"European Crohn\u2019s and Colitis Organisation; European Society of Pediatric Gastroenterology, Hepatology and Nutrition","year":"2014","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t20170713025134_CIT0004","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/01.mib.0000235835.32176.85","article-title":"A population-based study of the frequency of corticosteroid resistance and dependence in pediatric patients with Crohn\u2019s disease and ulcerative colitis","volume":"12","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20170713025134_CIT0005","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5414\/CN108044","article-title":"Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood","volume":"81","year":"2014","journal-title":"Clin Nephrol"},{"key":"key\n\t\t\t\t20170713025134_CIT0006","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/art.37754","article-title":"Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial","volume":"65","author":"RIM Study Group","year":"2013","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170713025134_CIT0007","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jaci.2005.03.028","article-title":"Adverse reactions to biologic agents: focus on autoimmune disease therapies","volume":"116","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"key\n\t\t\t\t20170713025134_CIT0008","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1586\/17474124.2014.881715","article-title":"Adverse events in IBD: to stop or continue immune suppressant and biologic treatment","volume":"8","year":"2014","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20170713025134_CIT0009","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-6405-8-23","article-title":"Opportunistic illnesses in Brazilian children with AIDS: results from two national cohort studies, 1983\u20132007","volume":"8","year":"2011","journal-title":"AIDS Res Ther"},{"key":"key\n\t\t\t\t20170713025134_CIT0010","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1097\/MPH.0000000000000584","article-title":"Safety and effectiveness of intravenous pentamidine for prophylaxis of Pneumocystis jirovecii pneumonia in pediatric hematology\/oncology patients","volume":"38","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"key":"key\n\t\t\t\t20170713025134_CIT0011","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12119","article-title":"Pneumocystis pneumonia in solid organ transplantation","volume":"13","author":"AST Infectious Diseases Community of Practice","year":"2013","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20170713025134_CIT0012","first-page":"CD005590","article-title":"Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients","volume":"10","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20170713025134_CIT0013","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170713025134_CIT0014","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10096-002-0758-5","article-title":"Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients","volume":"21","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"author":"US Food and Drug Administration","key":"key\n\t\t\t\t20170713025134_CIT0015"},{"key":"key\n\t\t\t\t20170713025134_CIT0016","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/pds.2331","article-title":"A systematic review of validated methods for identifying erythema multiforme major\/minor\/not otherwise specified, Stevens-Johnson syndrome, or toxic epidermal necrolysis using administrative and claims data","volume":"21","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"volume-title":"Discrete failure time models","year":"1997","key":"key\n\t\t\t\t20170713025134_CIT0017"},{"key":"key\n\t\t\t\t20170713025134_CIT0018","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.amjmed.2016.03.022","article-title":"Stevens-johnson syndrome and toxic epidermal necrolysis: an analysis of triggers and implications for improving prevention","volume":"129","year":"2016","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20170713025134_CIT0019","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.autrev.2008.07.010","article-title":"Use of glucocorticoids and risk of infections","volume":"8","year":"2008","journal-title":"Autoimmun Rev"},{"key":"key\n\t\t\t\t20170713025134_CIT0020","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM197712292972602","article-title":"Successful chemoprophylaxis for Pneumocystis carinii pneumonitis","volume":"297","year":"1977","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170713025134_CIT0021","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/jama.296.3.292","article-title":"Incidence of opportunistic and other infections in HIV-infected children in the HAART era","volume":"296","year":"2006","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170713025134_CIT0022","first-page":"795","article-title":"Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener\u2019s granulomatosis","volume":"151","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20170713025134_CIT0023","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5694\/j.1326-5377.1995.tb139873.x","article-title":"Pneumocystis carinii pneumonia in HIV-negative immunocompromised adults","volume":"162","year":"1995","journal-title":"Med J Aust"},{"key":"key\n\t\t\t\t20170713025134_CIT0024","first-page":"246","article-title":"Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases","volume":"21","year":"1994","journal-title":"J Rheumatol"},{"journal-title":"Clin Respir J","article-title":"Pneumocystis pneumonia in non-HIV children: a 10-year retrospective study","year":"2016","key":"key\n\t\t\t\t20170713025134_CIT0025"},{"key":"key\n\t\t\t\t20170713025134_CIT0026","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/art.37866","article-title":"Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis","volume":"65","author":"SABER Collaboration","year":"2013","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170713025134_CIT0027","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"RAVE-ITN Research Group","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170713025134_CIT0028","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/01.ju.0000130653.74548.d6","article-title":"Adverse reactions of nitrofurantoin, trimethoprim and sulfamethoxazole in children","volume":"172","year":"2004","journal-title":"J Urol"},{"key":"key\n\t\t\t\t20170713025134_CIT0029","doi-asserted-by":"crossref","first-page":"792","DOI":"10.7326\/0003-4819-124-9-199605010-00003","article-title":"Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group","volume":"124","year":"1996","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20170713025134_CIT0030","first-page":"CD005590","article-title":"Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20170713025134_CIT0031","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/imj.12599","article-title":"Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014","volume":"44","year":"2014","journal-title":"Intern Med J"},{"key":"key\n\t\t\t\t20170713025134_CIT0032","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/1574886311308020004","article-title":"A comparison of adverse drug reactions between high- and standard-dose trimethoprim-sulfamethoxazole in the ambulatory setting","volume":"8","year":"2013","journal-title":"Curr Drug Saf"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jpids\/article-pdf\/doi\/10.1093\/jpids\/pix052\/18538457\/pix052.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T09:54:47Z","timestamp":1569405287000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article-lookup\/doi\/10.1093\/jpids\/pix052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,13]]},"references-count":32,"URL":"https:\/\/doi.org\/10.1093\/jpids\/pix052","relation":{},"ISSN":["2048-7193","2048-7207"],"issn-type":[{"type":"print","value":"2048-7193"},{"type":"electronic","value":"2048-7207"}],"subject":[],"published":{"date-parts":[[2017,7,13]]}}}